![SBFM Stock Earnings: Sunshine Biopharma Beats EPS, Beats Revenue for Q1 2024 1 SBFM stock - SBFM Stock Earnings: Sunshine Biopharma Beats EPS, Beats Revenue for Q1 2024](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600-768x432.png)
Source: iQoncept / Shutterstock
Sunshine Biopharma (NASDAQ:SBFM) just reported results for the first quarter of 2024.
- Sunshine Biopharma reported earnings per share of -$2.00. This was above the analyst estimate for EPS of -$8.00.
- The company reported revenue of $7.54 million.
- This was 7.73% better than the analyst estimate for revenue of $7.00 million.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/05/sbfm-stock-earnings-sunshine-biopharma-for-q1-of-2024/.
©2024 InvestorPlace Media, LLC